MONTPELIER, Vt. (AP) -- Vermont's attorney general says the state will receive $136,000 as part of a national settlement with pharmaceutical manufacturer GlaxoSmithKline over allegations that the company sold defective drugs.
Attorney General William Sorrell says the settlement resolves allegations that the company manufactured and sold four products whose strength, purity and/or quality was below U.S. Food and Drug Administration standards.
The drugs were Paxil CR, a controlled release antidepressant; a diabetes medication called Avandamet; Kytril, an anti-nausea drug and Bactroban, an antibiotic ointment.
Sorrell said Thursday that the payment to Vermont represents damages equal to twice the amount the Vermont Medicaid program paid for the products.
Attorney General William Sorrell says the settlement resolves allegations that the company manufactured and sold four products whose strength, purity and/or quality was below U.S. Food and Drug Administration standards.
The drugs were Paxil CR, a controlled release antidepressant; a diabetes medication called Avandamet; Kytril, an anti-nausea drug and Bactroban, an antibiotic ointment.
Sorrell said Thursday that the payment to Vermont represents damages equal to twice the amount the Vermont Medicaid program paid for the products.
